{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:51:27Z","timestamp":1771955487573,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1245\/s10434-012-2461-9","type":"journal-article","created":{"date-parts":[[2012,7,2]],"date-time":"2012-07-02T15:20:18Z","timestamp":1341242418000},"page":"4262-4269","source":"Crossref","is-referenced-by-count":64,"title":["Ki-67 is a Prognostic Biomarker of Survival after Radiofrequency Ablation of Liver Malignancies"],"prefix":"10.1245","volume":"19","author":[{"given":"Constantinos T.","family":"Sofocleous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia M.","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mithat","family":"Gonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen T.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn A.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Covey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"DeMatteo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy E.","family":"Kemeny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"2461_CR1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1665-2681(19)32034-4","volume":"5","author":"D Motola-Kuba","year":"2006","unstructured":"Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N. Hepatocellular carcinoma. An overview. Ann Hepatol. 2006;5:16\u201324.","journal-title":"Ann Hepatol."},{"key":"2461_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00423-005-0012-6","volume":"391","author":"P Hildebrand","year":"2006","unstructured":"Hildebrand P, Kleemann M, Roblick UJ, et al. Radiofrequency-ablation of unresectable primary and secondary liver tumors: results in 88 patients. Langenbecks Arch Surg. 2006;391:1\u20136.","journal-title":"Langenbecks Arch Surg."},{"key":"2461_CR3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3816\/CCC.2004.n.012","volume":"4","author":"NN Hanna","year":"2004","unstructured":"Hanna NN. Radiofrequency ablation of primary and metastatic hepatic malignancies. Clin Colorectal Cancer. 2004;4:92\u2013100.","journal-title":"Clin Colorectal Cancer."},{"key":"2461_CR4","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/sj.bjc.6602582","volume":"92","author":"AR Gillams","year":"2005","unstructured":"Gillams AR. The use of radiofrequency in cancer. Br J Cancer. 2005;92:1825\u20139.","journal-title":"Br J Cancer."},{"key":"2461_CR5","first-page":"99","volume":"10","author":"SA Curley","year":"2002","unstructured":"Curley SA, Izzo F. Radiofrequency ablation of primary and metastic liver tumors. Surg Technol Int. 2002;10:99\u2013106.","journal-title":"Surg Technol Int."},{"key":"2461_CR6","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.v11.i40.6395","volume":"11","author":"MH Chen","year":"2005","unstructured":"Chen MH, Yang W, Yan K, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005;11:6395\u2013401.","journal-title":"World J Gastroenterol."},{"key":"2461_CR7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2214\/AJR.07.2198","volume":"189","author":"CT Sofocleous","year":"2007","unstructured":"Sofocleous CT, Nascimento RG, Gonen M, et al. Radiofrequency ablation in the management of liver metastases from breast cancer. Am J Roentgenol. 2007;189:883\u20139.","journal-title":"Am J Roentgenol."},{"key":"2461_CR8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1148\/radiol.2533081968","volume":"253","author":"MF Meloni","year":"2009","unstructured":"Meloni MF, Andreano A, Laeseke PF, Livraghi T, Sironi S, Lee FT Jr. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation\u2014intermediate and long-term survival rates. Radiology. 2009;253:861\u20139.","journal-title":"Radiology."},{"key":"2461_CR9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4240\/wjgs.v2.i4.128","volume":"2","author":"H Rhim","year":"2010","unstructured":"Rhim H, Lim HK, Choi D. Current status of radiofrequency ablation of hepatocellular carcinoma. World J Gastrointest Surg. 2010;2:128\u201336.","journal-title":"World J Gastrointest Surg."},{"key":"2461_CR10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00270-008-9384-7","volume":"32","author":"TF Jakobs","year":"2009","unstructured":"Jakobs TF, Hoffmann RT, Schrader A, et al. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. Cardiovasc Intervent Radiol. 2009;32:38\u201346.","journal-title":"Cardiovasc Intervent Radiol."},{"key":"2461_CR11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archsurg.141.2.181","volume":"141","author":"LM Sutherland","year":"2006","unstructured":"Sutherland LM, Williams JA, Padbury RT, Gotley DC, Stokes B, Maddern GJ. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141:181\u201390.","journal-title":"Arch Surg."},{"key":"2461_CR12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.suronc.2005.01.001","volume":"14","author":"KK Ng","year":"2005","unstructured":"Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005;14:41\u201352.","journal-title":"Surg Oncol."},{"key":"2461_CR13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiology.217.1.r00se02119","volume":"217","author":"S Rossi","year":"2000","unstructured":"Rossi S, Garbagnati F, Lencioni R, et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology. 2000;217:119\u201326.","journal-title":"Radiology."},{"key":"2461_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1072-7515(03)00750-6","volume":"197","author":"LE Harrison","year":"2003","unstructured":"Harrison LE, Koneru B, Bahramipour P, et al. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma. J Am Coll Surg. 2003;197:759\u201364.","journal-title":"J Am Coll Surg."},{"key":"2461_CR15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11605-007-0100-8","volume":"11","author":"RR White","year":"2007","unstructured":"White RR, Avital I, Sofocleous CT, et al. Rates and patterns of recurrence for percutaneous radiofrequency ablation and open wedge resection for solitary colorectal liver metastasis. J Gastrointest Surg. 2007;11:256\u201363.","journal-title":"J Gastrointest Surg."},{"key":"2461_CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1148\/radiol.2262012198","volume":"226","author":"T Livraghi","year":"2003","unstructured":"Livraghi T, Solbiati L, Meloni MF, Gazelle EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441\u201351.","journal-title":"Radiology."},{"key":"2461_CR17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/00004424-200411000-00007","volume":"39","author":"R Lencioni","year":"2004","unstructured":"Lencioni R, Crocetti L, Cioni D, Della Pina C, Bartolozzi C. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol. 2004;39:689\u201397.","journal-title":"Invest Radiol."},{"key":"2461_CR18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000080886","volume":"21","author":"TJ White","year":"2004","unstructured":"White TJ, Roy-Choudhury SH, Breen DJ, et al. Percutaneous radiofrequency ablation of colorectal hepatic metastases\u2014initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases. Dig Surg. 2004;21:314\u201320.","journal-title":"Dig Surg."},{"key":"2461_CR19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s004640000067","volume":"14","author":"A Siperstein","year":"2000","unstructured":"Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations. Surg Endosc. 2000;14:400\u20135.","journal-title":"Technical considerations. Surg Endosc."},{"key":"2461_CR20","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/archsurg.137.12.1332","volume":"137","author":"R Adam","year":"2002","unstructured":"Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332\u20139.","journal-title":"Arch Surg."},{"key":"2461_CR21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000194946","volume":"26","author":"N Snoeren","year":"2009","unstructured":"Snoeren N, Jansen MC, Rijken AM, et al. Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Dig Surg. 2009;26:56\u201362.","journal-title":"Dig Surg."},{"key":"2461_CR22","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1148\/radiol.2491071752","volume":"249","author":"CT Sofocleous","year":"2008","unstructured":"Sofocleous CT, Nascimento RG, Petrovic LM, et al. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology. 2008;249:364\u201374.","journal-title":"Radiology."},{"key":"2461_CR23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.cellbio.15.1.269","volume":"15","author":"I Budihardjo","year":"1999","unstructured":"Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269\u201390.","journal-title":"Annu Rev Cell Dev Biol."},{"key":"2461_CR24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1471-2407-6-203","volume":"6","author":"J Yang","year":"2006","unstructured":"Yang J, Ramnath N, Moysich KB, et al. Prognostic significance of MCM2, Ki-67 and gelsolin in non\u2013small cell lung cancer. BMC Cancer. 2006;6:203.","journal-title":"BMC Cancer."},{"key":"2461_CR25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2214\/ajr.177.4.1770777","volume":"177","author":"GD Dodd 3rd","year":"2001","unstructured":"Dodd GD 3rd, Frank MS, Aribandi M, Chopra S, Chintapalli KN. Radiofrequency thermal ablation: computer analysis of the size of the thermal injury created by overlapping ablations. AJR Am J Roentgenol. 2001;177:777\u201382.","journal-title":"AJR Am J Roentgenol."},{"key":"2461_CR26","doi-asserted-by":"crossref","unstructured":"Choi H, Loyer EM, DuBrow RA, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. Radiographics. 2001;21(Spec. No.):S41\u201354.","DOI":"10.1148\/radiographics.21.suppl_1.g01oc08s41"},{"key":"2461_CR27","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1148\/radiol.2353042205","volume":"235","author":"SN Goldberg","year":"2005","unstructured":"Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005 235:728\u201339.","journal-title":"Radiology."},{"key":"2461_CR28","first-page":"159","volume":"101","author":"F Graur","year":"2006","unstructured":"Graur F, Vlad L, Furcea L, Miclaus D, Osian G. Radiofrequency ablation of liver tumors: technique and preliminary results. Chirurgia (Bucur). 2006;101:159\u201367.","journal-title":"Chirurgia (Bucur)."},{"key":"2461_CR29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1245\/ASO.2003.07.017","volume":"10","author":"SA Curley","year":"2003","unstructured":"Curley SA. Radiofrequency ablation of malignant liver tumors. Ann Surg Oncol. 2003;10:338\u201347.","journal-title":"Ann Surg Oncol."},{"key":"2461_CR30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2214\/ajr.170.4.9530052","volume":"170","author":"S Rossi","year":"1998","unstructured":"Rossi S, Buscarini E, Garbagnati F, et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol. 1998;170:1015\u201322.","journal-title":"AJR Am J Roentgenol."},{"key":"2461_CR31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1148\/radiology.205.2.9356616","volume":"205","author":"L Solbiati","year":"1997","unstructured":"Solbiati L, Goldberg SN, Ierace T, et al. Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. Radiology. 1997;205:367\u201373.","journal-title":"Radiology."},{"key":"2461_CR32","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0041-1345(00)02577-X","volume":"33","author":"A Pulvirenti","year":"2001","unstructured":"Pulvirenti A, Garbagnati F, Regalia E, et al. Experience with radiofrequency ablation of small hepatocellular carcinomas before liver transplantation. Transplant Proc. 2001;33:1516\u20137.","journal-title":"Transplant Proc."},{"key":"2461_CR33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2214\/ajr.183.1.1830209","volume":"183","author":"CT Sofocleous","year":"2004","unstructured":"Sofocleous CT, Klein KM, Hubbi B, et al. Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. AJR Am J Roentgenol. 2004;183:209\u201313.","journal-title":"AJR Am J Roentgenol."},{"key":"2461_CR34","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1200\/JCO.2005.07.501","volume":"23","author":"A Urruticoechea","year":"2005","unstructured":"Urruticoechea A, Smith IE, Dowsett M. Proliferation marker Ki-67 in early breast cancer. J Clin Oncol. 2005;23:7212\u201320.","journal-title":"J Clin Oncol."},{"key":"2461_CR35","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/cncr.22840","volume":"110","author":"MK Tollefson","year":"2007","unstructured":"Tollefson MK, Thompson RH, Sheinin Y, et al. Ki-67 and coagulative tumor necrosis are independent predictors of poor outcome for patients with clear cell renal carcinoma and not surrogates for each other. Cancer. 2007;110:783\u201390.","journal-title":"Cancer."},{"key":"2461_CR36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1746.1998.01555.x","volume":"13","author":"KL King","year":"1998","unstructured":"King KL, Hwang JJ, Chau GY, et al. Ki-67 expression as a prognostic marker in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 1998;13:273\u20139.","journal-title":"J Gastroenterol Hepatol."},{"key":"2461_CR37","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2004.10.042","volume":"22","author":"MM Garrity","year":"2004","unstructured":"Garrity MM, Burgart LJ, Mahoney MR, et al. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes\u2019 B2 or C colon cancer: a North Central Cancer Treatment Group study. J Clin Oncol. 2004;22:1572\u201382.","journal-title":"J Clin Oncol."},{"key":"2461_CR38","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1023\/A:1020187211376","volume":"47","author":"C Toquet","year":"2002","unstructured":"Toquet C, Le Neel JC, Guillou L, et al. Elevated (>\u00a0or\u00a0=\u00a010\u00a0%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig Dis Sci. 2002;47:2247\u201353.","journal-title":"Dig Dis Sci."},{"key":"2461_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1677\/ERC-06-0074","volume":"14","author":"E Vilar","year":"2007","unstructured":"Vilar E, Salazar R, P\u00e9rez-Garc\u00eda J, Cortes J, Oberg K, Tabernero J. Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors. Endocr Relat Cancer. 2007;14:221\u201332.","journal-title":"Endocr Relat Cancer."},{"key":"2461_CR40","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0002-9610(01)00656-0","volume":"182","author":"JC Weber","year":"2001","unstructured":"Weber JC, Nakano H, Bachellier P, et al. Is a proliferation index of cancer cells a reliable prognostic factor after hepatectomy in patients with colorectal liver metastases? Am J Surg. 2001;182:81\u20138.","journal-title":"Am J Surg."},{"key":"2461_CR41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3748\/wjg.v11.i10.1439","volume":"11","author":"HC Yu","year":"2005","unstructured":"Yu HC, Cheng JS, Lai KH, et al. Factors for early tumor recurrence of single small hepatocellular carcinoma after percutaneous radiofrequency ablation therapy. World J Gastroenterol. 2005;11:1439\u201344.","journal-title":"World J Gastroenterol."},{"key":"2461_CR42","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1245\/s10434-011-1762-8","volume":"18","author":"N Snoeren","year":"2011","unstructured":"Snoeren N, Huiskens J, Rijken AM, et al. Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol. 2011;18:3702\u201310.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2461-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-012-2461-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-012-2461-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:47:52Z","timestamp":1572972472000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-012-2461-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":42,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2461"],"URL":"https:\/\/doi.org\/10.1245\/s10434-012-2461-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]}}}